Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Zongertinib is a human HER2-selective tyrosine kinase inhibitor, a novel TK that is highly selective for covalent binding to the HER2 tyrosine kinase domain (TKD).Zongertinib exhibits antitumor activity with inhibitory effects on pHER2 and EGF.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 34,000 | |||
5 mg | 在庫あり | ¥ 85,500 | |||
10 mg | 在庫あり | ¥ 114,000 | |||
25 mg | 在庫あり | ¥ 227,000 | |||
50 mg | 在庫あり | ¥ 360,500 | |||
100 mg | 在庫あり | ¥ 581,000 | |||
500 mg | 在庫あり | ¥ 1,141,000 |
説明 | Zongertinib is a human HER2-selective tyrosine kinase inhibitor, a novel TK that is highly selective for covalent binding to the HER2 tyrosine kinase domain (TKD).Zongertinib exhibits antitumor activity with inhibitory effects on pHER2 and EGF. |
別名 | BI 764532, BI 1810631 |
分子量 | 535.6 |
分子式 | C29H29N9O2 |
CAS No. | 2728667-27-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 28 mg/mL (52.28 mM), Sonication and heating are recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Zongertinib 2728667-27-2 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors HER Tyrosine Kinases BI1810631 BI 764532 BI-1810631 BI 1810631 BI764532 BI-764532 Inhibitor inhibitor inhibit